SynthesisSleep & breathing = Schlaf & Atmung2025
The impact of sleep disturbances in individuals with comorbid diabetes and chronic kidney disease: a systematic review.
Synthesis in Sleep & breathing = Schlaf & Atmung, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Sleep Quality and Its Independent Correlates in Patients with Diabetic Kidney Disease: A Retrospective Network.International journal of general medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeDiabetes and chronic kidney disease (CKD) frequently co-occur and lead to high morbidity and mortality. Although sleep disturbances are linked to adverse glycemic and renal outcomes, their impact in individuals with both conditions remains unclear. This study systemically reviewed the impact of sleep disturbances on health outcomes in comorbid diabetes and CKD.
methodsA systematic search of CINAHL, EMBASE, MEDLINE-Ovid, Web of Science was conducted in August 2024. Studies were included if CKD was defined as estimated glomerular filtration rate < 60 mL/min/1.73 m², urinary albumin-to-creatinine ratio > 30 mg/g, or clinical diagnosis, and diabetes by clinical diagnosis.
resultsSeven studies were selected (four cross-sectional and three randomized control trials). Individuals with comorbid diabetes and CKD who had sleep disturbances (obstructive sleep apnea, insomnia, short or long sleep duration) showed poorer renal function, higher body mass index, arterial stiffness and coronary calcification, inflammatory markers, anxiety and depression than those without sleep disturbances. Continuous positive airway pressure reduced albuminuria and improved glycemic outcomes in comorbid diabetes and CKD with OSA. Melatonin supplementation improved sleep quality, glycemic control, and reduced psychological distress in comorbid diabetes and CKD.
conclusionIndividuals with comorbid diabetes and CKD who experience sleep disturbances have worse renal, cardiovascular, and psychological outcomes than those without sleep disturbances, and improving OSA and sleep quality has a positive impact on health outcomes. Addressing sleep disturbances may help slow disease progression and improve cardiovascular and mental health, supporting routine screening and targeted sleep management in this population.
Indexed as
Identifiers
41381785What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.